Table 1.

Demographics and asthma severity of participants n=37

Child age	Mean 7.7 years
Insurance status
Public	15(41%)
Private	18(49%)
Unknown	4 (11%)
Parent race/ethnicity
White	13(35%)
African-American	17 (46%)
Latino	7 (19%)
Parent education
<High school	4 (11%)
High school graduate	9 (24%)
Some college	8 (22%)
College degree or higher	7 (19%)
Unknown	9 (24%)
Family income (yearly)
<$20,000	11(30%)
$21,000<$40,000	5 (14%)
$41,000<$80,000	4 (11%)
>$80,000	4 (11%)
Unknown	13(35%)
Reason for visit
Asthma flare	16 (43%)
Well-child visit	11(30%)
Asthma follow-up	3 (8%)
Non-asthma specific sick visit	7 (19%)
Asthma severity*
1. Days with wheezing, chest tightness, cough, or shortness of breath:
≤ 4 days	25 (68%)
≥ 4 days	12 (32%)
2. Days child had to slow down or stop his/her play or activities because of asthma, wheezing, chest tightness, cough, or shortness of breath?
≤ 4 days	31 (84%)
≥ 4 days	6 (16%)
3. Nights child woke up because of asthma, wheezing, chest tightness, cough, or shortness of breath?
≤ 2days	26 (72%)
≥ 3 days	11 (28%)
Controller medications prescribed #
Inhaled corticosteroids (Flovent, Pulmicort)	33
Inhaled cromones	2
Oral montelukast (Leukotrine modifier)	3

^*During the last 2 weeks (if not currently symptomatic), or during the 2 weeks before the current flare began (if currently symptomatic), based on criteria for persistent asthma from the National Asthma Education and Prevention Program.

^#A child may have more than one controller medication prescribed.